Mingkuan Fan, Yushu Liu, Kui Liu, Canyou Zhang, Yuhong Li, Xiaoqiu Liu, Hui Zhang, Jun Cheng
{"title":"Constructing a Resilience Assessment Index System for Tuberculosis Healthcare Services Under Public Health Emergencies: A Modified Delphi Study.","authors":"Mingkuan Fan, Yushu Liu, Kui Liu, Canyou Zhang, Yuhong Li, Xiaoqiu Liu, Hui Zhang, Jun Cheng","doi":"10.2147/RMHP.S506867","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Understanding the resilience of tuberculosis healthcare services (TB-HSs) is crucial for the targeted reinforcement of weak links and mitigation of the impact of public health emergencies (PHEs). However, assessment systems in this domain are lacking. This study aims to construct a resilience assessment index system (RAIS) for TB-HSs in China.</p><p><strong>Methods: </strong>The following four-step design process was conducted: 1) establishing the RAIS index pool based on a literature review, 2) designing an initial RAIS for TB-HSs following Donabedian's \"structure-process-outcome\" framework through expert meetings; 3) employing a two-round Delphi survey to obtain a consensus on the RAIS; and 4) using the analytic hierarchy process to quantify the weight of each indicator included in the final RAIS.</p><p><strong>Results: </strong>The expert panel (n=26) had 100.0% and 96.2% response rates in the first and second Delphi rounds, respectively. The expert authority coefficients for the two rounds were 0.908 and 0.906. Both rounds showed high levels of expert coordination (<i>P</i><0.001). The final RAIS comprising three first-grade, nine second-grade, and 39 third-grade indicators. Our findings reveal that tuberculosis service provision/utilization tops the first-grade indicators, weighing 49.05%. Among the second-grade indicators, service outcomes (20.79%) and patient treatment (20.67%) were the top-weighted. Of the third-grade indicators, the treatment discontinuation proportion (10.29%) and the treatment coverage rate in confirmed TB patients (8.90%), were critical components in evaluating the resilience of TB-HSs.</p><p><strong>Conclusion: </strong>This study developed a unified hierarchical resilience assessment index system for TB-HSs in China. Further research is required to validate and improve our results. The study's findings could help develop strategies that benefit public health.</p>","PeriodicalId":56009,"journal":{"name":"Risk Management and Healthcare Policy","volume":"18 ","pages":"1057-1067"},"PeriodicalIF":2.7000,"publicationDate":"2025-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11956713/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Risk Management and Healthcare Policy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/RMHP.S506867","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: Understanding the resilience of tuberculosis healthcare services (TB-HSs) is crucial for the targeted reinforcement of weak links and mitigation of the impact of public health emergencies (PHEs). However, assessment systems in this domain are lacking. This study aims to construct a resilience assessment index system (RAIS) for TB-HSs in China.
Methods: The following four-step design process was conducted: 1) establishing the RAIS index pool based on a literature review, 2) designing an initial RAIS for TB-HSs following Donabedian's "structure-process-outcome" framework through expert meetings; 3) employing a two-round Delphi survey to obtain a consensus on the RAIS; and 4) using the analytic hierarchy process to quantify the weight of each indicator included in the final RAIS.
Results: The expert panel (n=26) had 100.0% and 96.2% response rates in the first and second Delphi rounds, respectively. The expert authority coefficients for the two rounds were 0.908 and 0.906. Both rounds showed high levels of expert coordination (P<0.001). The final RAIS comprising three first-grade, nine second-grade, and 39 third-grade indicators. Our findings reveal that tuberculosis service provision/utilization tops the first-grade indicators, weighing 49.05%. Among the second-grade indicators, service outcomes (20.79%) and patient treatment (20.67%) were the top-weighted. Of the third-grade indicators, the treatment discontinuation proportion (10.29%) and the treatment coverage rate in confirmed TB patients (8.90%), were critical components in evaluating the resilience of TB-HSs.
Conclusion: This study developed a unified hierarchical resilience assessment index system for TB-HSs in China. Further research is required to validate and improve our results. The study's findings could help develop strategies that benefit public health.
期刊介绍:
Risk Management and Healthcare Policy is an international, peer-reviewed, open access journal focusing on all aspects of public health, policy and preventative measures to promote good health and improve morbidity and mortality in the population. Specific topics covered in the journal include:
Public and community health
Policy and law
Preventative and predictive healthcare
Risk and hazard management
Epidemiology, detection and screening
Lifestyle and diet modification
Vaccination and disease transmission/modification programs
Health and safety and occupational health
Healthcare services provision
Health literacy and education
Advertising and promotion of health issues
Health economic evaluations and resource management
Risk Management and Healthcare Policy focuses on human interventional and observational research. The journal welcomes submitted papers covering original research, clinical and epidemiological studies, reviews and evaluations, guidelines, expert opinion and commentary, and extended reports. Case reports will only be considered if they make a valuable and original contribution to the literature. The journal does not accept study protocols, animal-based or cell line-based studies.